We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New AI Technology Can Determine Best Type of Cancer Treatment

By HospiMedica International staff writers
Posted on 23 Jan 2019
A team of researchers from Case Western Reserve University (Cleveland, OH, USA) is using artificial intelligence (AI) and smart-imaging computer technology for viewing routine medical images — MRIs, CAT scans, tissue biopsies — to determine the best type of cancer treatment.

In addition to detecting patterns beyond what the human eye can see, AI and computers can also determine the likelihood that a patient is going to respond to chemotherapy. A significant number of patients receive a cancer diagnosis, but also get over-treated and over-diagnosed. A recent study in the American Journal of Medicine found that 42% of new cancer patients lose their complete life savings in two years for treatment.

Image: New AI technology can help reduce the number of biopsies and surgeries for cancer patients (Photo courtesy of Case Western Reserve University).
Image: New AI technology can help reduce the number of biopsies and surgeries for cancer patients (Photo courtesy of Case Western Reserve University).

The researchers believe that a significant reduction can be brought about in the number of surgeries and of biopsies in patients who do not require them because they have benign nodules. Their research has been able to determine whether breast cancer patients, and more recently lung cancer patients, need chemotherapy. The technology would not reduce the number of jobs for pathologists or radiologists, but assist them and other clinicians.

Related Links:
Case Western Reserve University

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Pre-Op Planning Solution
Sectra 3D Trauma

Latest AI News

AI-Powered Algorithm to Revolutionize Detection of Atrial Fibrillation

AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors

New Model Predicts 10 Year Breast Cancer Risk